Latest Capital Markets News

Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.

North Stawell Minerals has reported a standout high-grade gold intercept at its Darlington target, reinforcing the potential for a Mariners-type mineralisation repeat in Victoria’s Stawell Corridor. Meanwhile, Wildwood drilling confirms geological promise despite lower grades.

Global Uranium and Enrichment Limited has completed a transformative acquisition of the Pine Ridge Uranium Project in Wyoming, backed by a A$10 million capital raise and strategic partnership with Snow Lake Energy. This positions the company for near-term uranium production in the US’s premier ISR basin while advancing multiple other uranium assets.

Midas Minerals has identified multiple drill-ready gold targets at its Newington Project in Western Australia, with drilling planned for the September quarter pending approvals. Meanwhile, exploration continues at the Challa Project as assay results are awaited.

Arizona Lithium advances its Prairie Project with a pioneering commercial development plan for lithium brine extraction, regulatory approvals, and a $1.3 million capital raise to fund initial production.

Boab Metals has inked a A$10 million deal to acquire the DeGrussa Processing Plant from Sandfire Resources, significantly derisking and reducing upfront capital costs for its Sorby Hills Project. Completion hinges on a final investment decision expected in the second half of 2025.

Perpetual Resources has raised $500,000 through a strongly supported placement to fund its maiden lithium drilling campaign at the Igrejinha Project in Brazil, following high-grade assay results that have boosted investor confidence.

Omni Bridgeway reports robust investment performance for FY25, highlighted by record proceeds and a landmark Fund 9 transaction that strengthens its balance sheet and strategic position.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

Helios Energy has confirmed significant contingent resources at its Presidio Project in West Texas, supported by new technical partnerships and a strengthened leadership team. The company raised $4.3 million to advance its development plans amid a shifting US energy landscape.

Jupiter Mines reported a robust Q3 FY2025 with higher manganese production and sales at Tshipi, driving a 65% jump in EBITDA amid improved prices and reduced costs.